With a compound annual growth rate (CAGR) of 5% from 2023 to 2033, the global focal segmentmental glomerulosclerosis (FSGS) therapeutics market is projected to reach a market size of US$ 4.89 billion by 2033 from US$ 3 billion in 2023. Focal Segmental Glomerulosclerosis (FSGS) Therapeutics saw a 3.5% compound annual growth rate (CAGR) in market …